CoDon AG
LSE:0Q37
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
CoDon AG
LSE:0Q37
|
DE |
|
C
|
China Yuchai International Ltd
F:CYD
|
SG |
|
C
|
China Yuchai International Ltd
XMUN:CYD
|
SG |
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value for CoDon AG.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What CoDon Does
co.don AG engages in cell cultivation for the regenerative treatment of articular cartilage defects. The firm develops, produces, and distributes autologous cell therapies for the minimally invasive repair of cartilage defects, it manufactures cell-based biological drugs for the use in orthopedic and neurosurgical applications. Its products are used for the treatment of focal cartilage defects, lumbar disc herniation, non-union fractures, and dental disorders.
- Headquarters
- Germany DE
- Employees
- 134
- IPO date
- Feb 1, 2001